WHO advisers recommend sticking with monovalent COVID XBB.1.5 vaccines Current vaccines neutralize current variants, but there are limited data on the impact against JN.1, a steadily rising part of the BA.2.86 family. CIDRAP

The World Health Organization (WHO) technical advisory group on COVID-19 vaccine composition met last week to review the latest SARS-CoV-2 genetic changes and assess if any vaccine changes are needed, and today the group recommended sticking with the current monovalent XBB.1.5 antigen.  ...

ALSO SEE: WHO Statement on the antigen composition of COVID-19 vaccines